Saturday, August 23, 2025

Life Sciences

Evaxion
Evaxion Biotech A/S, a clinical-stage TechBio company focused on developing AI-Immunology™-powered vaccines is pleased to present its novel precision vaccine concept at the 65th Annual Meeting of the American Society of Hematology (ASH), December 9-12, 2023, in San Diego, California. Selected for Oral Presentation –  Evaxion was selected for oral presentation...
Lantern Pharma
Lantern Pharma Inc., an artificial intelligence (“AI”) company developing targeted and transformative cancer therapies using its proprietary RADR AI and machine learning (“ML”) platform with multiple clinical-stage drug programs, announced that the U.S. Food and Drug Administration (FDA) has granted LP-284 Orphan Drug Designation (ODD) for the treatment of...
Empatica
Empatica, a digital health and AI company developing medical-grade wearables and digital biomarkers for health monitoring and diagnostics, announced plans to launch a first-of-its-kind study aimed at developing of a seizure prediction algorithm for people with epilepsy, based on real-world data collected using the company's technology. According to figures from the...
ZoomRx
Global life sciences consulting firm ZoomRx is set to transform how life sciences brands monitor and evaluate TV ad campaigns with today’s launch of ZoomRx TV Tracking. ZoomRx TV Tracking combines two distinct assets – custom-built panels of verified patients and patent-pending mobile technology – to measure individual-level TV...
ENDRA Life Sciences
ENDRA Life Sciences Inc., a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that the United States Patent and Trademark Office has issued to ENDRA a new patent, U.S. Patent No. 11828727 (the ‘727 patent) titled “Thermoacoustic Probe.” The ‘727 patent relates to a thermoacoustic probe design with an optical...
Phenomic AI
Phenomic AI announced that they have entered into a strategic collaboration and licensing agreement with Boehringer Ingelheim to discover targets important in stroma-rich cancers. The partners will leverage Phenomic’s expertise in target identification and stromal biology based on its scTx® single-cell transcriptomics platform which will greatly enhance Boehringer’s efforts to...
Veracyte
Veracyte, Inc. announced that clinical validation data published in the journal CHEST show that the company’s Percepta Nasal Swab test determines lung cancer risk, with high accuracy, among people who currently smoke or have previously smoked and have lung nodules. The findings suggest that the novel, non-invasive genomic test can help...
BostonGene
BostonGene, a leading provider of AI-driven, molecular and immune profiling solutions, announced that it has won the 2023 Fierce Life Sciences Innovation Award for its AI-driven clinical trials selection tool. The program, produced by Fierce Biotech and Fierce Pharma, recognizes innovations that exemplify effectiveness, technical innovation, competitive advantage, financial impact, and true innovation with...
Paige
At the Radiological Society of North America's 109th Scientific Assembly and Annual Meeting, Paige, a global leader in end-to-end digital pathology solutions and clinical AI applications that assist in diagnosing cancer, announced it has teamed up with Nuance, a Microsoft company, to create the largest digital consultation network in...
EVERSANA
Building on a promise to "pharmatize" artificial intelligence (AI) across the life sciences sector, EVERSANA, a leading provider of commercial services to the global life sciences industry, today announced the first of several new generative AI-based innovations on Amazon Web Services (AWS) to drive greater efficiency and business value for companies and...